In pharma, the question isn’t whether AI can be used — it’s how to use it responsibly, without putting regulatory submissions, scientific credibility, or patient safety at risk.

In our latest white paper, we look at how pharma library and medical information teams are building trust in AI, including:
- Understanding when outputs can be trusted and when human review is non-negotiable
- Knowing what makes AI outputs defensible under regulatory and scientific review
- Defining guardrails before adoptions scales

👉 Download the white paper to see how teams are approaching AI responsibly: https://readcube.wpenginepowered.com/en/white-papers/building-trust-in-… Nucleus&utm_campaign=RCwhitepaper&utm_term=readcube